Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. March 2006

Alma Muñoz M., Katia Abarca V., Vivian Luchsinger F., M. Teresa Valenzuela B., Jorge Jiménez De La J.

Resultado de la investigación: Contribución a una revistaReseña científicarevisión exhaustiva

4 Citas (Scopus)

Resumen

The article briefly reviews the epidemiology of rotavirus infection and the scientific information of the rotavirus vaccines: Rotashield® , withdrawen from the market due to its association with intussusception, Rotateq® currently in an advanced phase of development, and Rotarix® , recently licensed in Chile. Considering the available information, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases, summarizes its conclusions and makes recommendations for infants vaccination against rotavirus in our country.
Idioma originalInglés estadounidense
Páginas (desde-hasta)124-127
Número de páginas4
PublicaciónRevista Chilena de Infectologia
Volumen23
N.º2
EstadoPublicada - 1 jun 2006

Palabras clave

  • Infants
  • Intussusception
  • Rotavirus
  • Rotavirus vaccine

Huella

Profundice en los temas de investigación de 'Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. March 2006'. En conjunto forman una huella única.

Citar esto